Literature DB >> 8420276

Eosinophilic gastroenteritis: 10 years experience.

C M Lee1, C S Changchien, P C Chen, D Y Lin, I S Sheen, C S Wang, D I Tai, S M Sheen-Chen, W J Chen, C S Wu.   

Abstract

Eight patients (five men, three women), mean age 36.9 +/- 13.5 (17-60) yr, were diagnosed to have eosinophilic gastroenteritis. The condition was proved in five patients by biopsies through endoscope, and in three, by operation. All had hypereosinophilia (absolute eosinophil count of 1,337-21,787/cm3). According to Klein classification, two had mucosal disease, three had muscle layer disease, and three, subserosal disease. The most common symptoms were abdominal pain (100%), diarrhea (62.5%), vomiting (62.5%), and nausea (50%). Four patients (50%) had symptoms for more than 1 yr before diagnosis. Barium studies revealed mucosal edema and/or thickening of the small intestinal wall in three cases (including one case with ulceration), partial gastric outlet obstruction in one case, and narrowing of lumen of the terminal ileum in one case. Hypotonic duodenogram revealed double contour in one case. Ultrasound examination revealed thickening of the intestinal wall in two cases; computer tomography revealed thickening of the intestinal wall in one case. All patients were treated with steroid (40 mg/day for initial dose and relapse; 5-10 mg/day for maintenance). The symptoms subsided and the eosinophil counts returned to normal within 2 wk in seven patients and 1 month in one. Of six patients being followed up for 2-10 yr, one had remission, four needed small maintenance dose of steroid, and one suffered from relapse with intestinal perforation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8420276

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  56 in total

Review 1.  Eosinophilic gastroenteritis with ascites: a case report and review of the literature.

Authors:  L M Fenoglio; V Benedetti; C Rossi; A Anania; K Wulhfard; M Trapani; E Scalabrino; G Alberto; D Novero; P Cavalloperin
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

2.  A dramatic response to ketotifen in a case of eosinophilic gastroenteritis mimicking abdominal emergency.

Authors:  Fusun F Bolukbas; Cengiz Bolukbas; Ali Uzunkoy; Fusun Baba; Mehmet Horoz; Ebru Ozturk
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

3.  Leukotriene receptor antagonists as potential steroid sparing agents in a patient with serosal eosinophilic gastroenteritis.

Authors:  M C Urek; M Kujundzić; M Banić; R Urek; T S Veic; D Kardum
Journal:  Gut       Date:  2006-09       Impact factor: 23.059

4.  Eosinophilic gastroenteritis causing stenosis of bulbo-duodenal junction: medical and endoscopic management.

Authors:  Sohail Ashraf; Imran Ashraf; Mohammad Alkarawi; Abdul Haleem; Khalid Bzeizi
Journal:  BMJ Case Rep       Date:  2009-07-14

5.  Subserosal eosinophilic gastroenteritis treated efficaciously with sodium cromoglycate.

Authors:  A Pérez-Millán; J L Martín-Lorente; A López-Morante; L Yuguero; F Sáez-Royuela
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

Review 6.  A review of eosinophilic gastroenteritis.

Authors:  Muhammad Ahsan Baig; Abdul Qadir; Javeria Rasheed
Journal:  J Natl Med Assoc       Date:  2006-10       Impact factor: 1.798

Review 7.  Eosinophilic gastroenteritis: a review.

Authors:  Hwa Eun Oh; Runjan Chetty
Journal:  J Gastroenterol       Date:  2008-10-29       Impact factor: 7.527

Review 8.  Eosinophilic gastroenteritis: epidemiology, diagnosis and management.

Authors:  Seema Khan; Susan R Orenstein
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 9.  Eosinophilic gastroenteritis.

Authors:  Rahim Daneshjoo; Nicholas J Talley
Journal:  Curr Gastroenterol Rep       Date:  2002-10

10.  Eosinophilic gastroenteritis: clinical experience with 15 patients.

Authors:  Ming-Jen Chen; Cheng-Hsin Chu; Shee-Chan Lin; Shou-Chuan Shih; Tsang-En Wang
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.